Ritesh International board approved the notice for its Annual General Meeting on August 29, 2026. The meeting is scheduled for September 28 at the company’s registered office in Punjab.

The board also approved the re-appointment of Mr. Ritesh Arora as Managing Director and revised remuneration for Wholetime Director Mr. Rijul Arora. Both actions require shareholder approval at the upcoming general meeting.

Key Board Approvals

The board meeting concluded with several administrative and compliance-related approvals:

• Re-appointment of Mr. Ritesh Arora (DIN: 00080156) as Managing Director.
• Revision in remuneration payable to Mr. Rijul Arora (DIN: 07477956).
• Appointment of CA Keshav Madaan as Internal Auditor for FY27.
• Appointment of M/s Verma Khushwinder & Co. as Cost Auditor for FY27.
• Appointment of CS Ansh Bhambri as scrutinizer for remote e-voting and the AGM.

Auditor Appointments

The board appointed new auditors for the financial year ending March 31, 2027.

AGM Details

The Annual General Meeting will be held on Monday, September 28, 2026, at 11:00 am. The venue is the registered office located at Momnabad Road, Village Akbarpura, District Sangrur, Punjab.

The book closure period for share transfers is fixed from September 23, 2026, to September 28, 2026. Shareholders must hold records within this window to participate in voting and receive dividends if declared.

Ritesh International has approved a 50% expansion of its manufacturing capacity at its Ahmedgarh facility to address rising demand for stearic acid, fatty acid, and glycerin. The company plans to increase its daily production capability from 80 metric tons to 120 metric tons, with commercial operations expected to begin in Q1 FY27-28.

The expansion involves a total capital expenditure of ₹7 crore. Financing will be structured through a mix of long-term bank loans amounting to approximately ₹1 crore and internal accruals covering the balance of ₹6 crore. The project is scheduled for completion within approximately eight months.

Strategic Implications

Ritesh Arora, Chairman and Managing Director, stated that existing facilities are operating near peak capacity utilization. The expansion aims to strengthen market share and enhance operating margins by meeting surging customer demand across core markets. The company emphasized that leveraging debt financing alongside internal accruals allows it to maintain a healthy balance sheet while positioning for sustained revenue growth.

What the Numbers Show

The funding structure reveals a strong reliance on internal resources, with internal accruals accounting for approximately 86% of the total ₹7 crore capital expenditure. This suggests limited incremental leverage pressure on the balance sheet, as only ₹1 crore is being raised through external long-term bank debt. This capital-light approach to expansion indicates the company’s current cash generation capabilities are sufficient to support significant capacity additions without heavily diluting equity or increasing interest burden proportionately.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rijul Arora, CFO and Wholetime Director, signed the intimation on August 17, 2026.